ABCA12 is involved in the transport of ceramides in skin, but may play a wider role in lipid metabolism. Here we show that in Abca12-deficient macrophages cholesterol efflux failed to respond to activation with LXR agonists. Abca12 deficiency caused a reduction in the abundance of Abca1, Abcg1 and Lxrβ; οverexpression of Lxrβ reversed the effects. 
Summary
ABCA12 is involved in the transport of ceramides in skin, but may play a wider role in lipid metabolism. Here we show that in Abca12-deficient macrophages cholesterol efflux failed to respond to activation with LXR agonists. Abca12 deficiency caused a reduction in the abundance of Abca1, Abcg1 and Lxrβ; οverexpression of Lxrβ reversed the effects.
Mechanistically, Abca12 deficiency did not affect the expression of genes involved in cholesterol metabolism. Instead, a physical association between Abca1, Abca12 and 3
Introduction:
Dysregulation of cholesterol homeostasis in macrophages is a pivotal event in the pathogenesis of atherosclerosis, the major cause of cardiovascular disease. Even small fluctuations of cellular cholesterol content cause apoptosis and necrosis. Macrophages, like all cells, possess a sophisticated regulatory network controlling cellular cholesterol homeostasis (Maxfield and Tabas, 2005) . These pathways control, on the one hand, cholesterol biosynthesis and uptake of cholesterol in low density lipoproteins and on the other, the release of cellular cholesterol to the extracellular acceptors, such as apolipoprotein A-I (apoA-I) or high density lipoprotein (HDL). While mechanisms controlling cholesterol delivery have been investigated in great detail (Brown and Goldstein, 2009) , the mechanisms responsible for regulation of cholesterol efflux are less clear. They are particularly relevant for macrophages, because cholesterol efflux in these cells is the major determinant of cholesterol homeostasis.
Three transporters responsible for regulated cholesterol efflux have been described: ABCA1, which is responsible for the efflux to lipid-free apoA-I, and ABCG1 and SR-B1, which regulate efflux to the mature HDL (Yvan-Charvet et al., 2010) . However, numerous studies indicate that our understanding of the regulation of cholesterol homeostasis is far from complete (for review see (Fitzgerald et al., 2010) ). We recently described a mouse carrying a mutation in another transporter, Abca12 (Smyth et al., 2008) , a gene best known for being mutated in a skin disease, Harlequin Ichthyosis. In the skin, ABCA12 plays a critical role in the transport of ceramides in keratinocytes (Kelsell et al., 2005) , however we found that in fibroblasts lacking Abca12 cholesterol homeostasis was also perturbed (Smyth et al., 2008) .
This prompted us to investigate the broader role of ABCA12 in cholesterol metabolism and the development of atherosclerosis.
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Results:

Abca12 deficiency impairs cholesterol efflux from macrophages
To examine the role of Abca12 in cholesterol efflux we derived macrophages from the fetal livers of mouse embryos carrying the El12 allele of Abca12 (Smyth et al., 2008) . ABCA1 is the sole determinant of specific cholesterol efflux to lipid-free apoA-I, therefore apoA-I was used as an acceptor to assess ABCA1-dependent efflux. In cells not activated with LXR agonist, cholesterol efflux to apoA-I was similar in cells of all genotypes (Fig. 1A ). (Fig. 1B) . Similar results were obtained with macrophages derived from mice carrying the independent Lx12 knockout allele of Abca12 (Yanagi et al., 2010) . Fetal macrophages with this mutation exhibited similar defects in cholesterol efflux to apoA-I (Fig. 1C) and HDL ( Fig. 1D ) upon activation with LXR agonist. Non-specific efflux was unaffected by loss of Abca12 (Supplemental Table S1 ). These observations were also confirmed in the RAW 264.7 mouse macrophage cells upon siRNA mediated Abca12 5 knockdown (Fig. 1E, F) . The effects of Abca12 deficiency on phospholipid efflux, a process also controlled by ABCA1, were similar to the effects on cholesterol efflux, except that phospholipid efflux was not impaired in heterozygous cells (Fig. 1G ).
Since LXR activation triggers upregulation of Abca1 and Abcg1 expression, we measured the effect of Abca12 deficiency on levels of these proteins. Abca12 depletion by siRNA Abca12 resulted in a substantial reduction in the levels of Abca1 and Abcg1, but not SR-B1, in cells activated with LXR agonist (Fig. 1H ). Lxrβ after Abca12 silencing was 58.5 ± 5.1 % of control (mean ± SEM; n=6). Collectively these data demonstrate that Abca12 deficiency impairs the ability of macrophages to upregulate the levels of key ABC transporters and cholesterol efflux in response to LXR activation. Both ABCA1 and ABCG1 are known to play a significant role in cellular cholesterol homeostasis. While the precise role of ABCG1 is still contentious, the role of ABCA1 is well established; we therefore focused more detailed mechanistic studies on the relationship between ABCA12 and ABCA1.
The role of Lxrβ in impairment of cholesterol efflux in Abca12-deficient cells
Given that LXR primarily mediates its effects via the regulation of gene transcription, we examined the impact of Abca12 deficiency on the expression of genes involved in lipid metabolism. Using real time RT-PCR we assessed mRNA levels of Lxrα, Lxrβ, two LXR target genes (Abca1 and Abcg1) and several other genes involved in cellular lipid metabolism (Ldlr, Scarb1, Msr1, Abca3, Hmgcr) . As expected, Abca12 mRNAwas undetectable in 6
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Lx12/Lx12 macrophages ( Fig. 2A ). Abca12 deficiency did not have a statistically significant effect on Abca1 and Abcg1 expression with or without stimulation by LXR agonists, nor on the expression of any other genes tested ( Fig. 2A) . Identical outcomes were observed when gene expression was analysed in RAW 264.7 cells with siRNA knockdown of Abca12 (Fig. 2B) . Thus, loss of Abca12 does not impair cholesterol efflux via transcriptional regulation of the key mediators of cholesterol homeostasis. This is to be expected, given the functional redundancy between Lxrβ and Lxrα, and only partial decrease of Lxrβ levels in Abca12-deficient cells.
To control for agonist-specific effects, we treated cells with a chemically distinct LXR agonist, GW3965 (Joseph et al., 2002) and observed similar results (Fig. 2C,D) . We also tested whether the effects of Abca12 deficiency are mediated through another regulator of ABC transporters, PPAR (Ogata et al., 2009) . Treatment with the PPARα/γ agonist RO4509851 did not reverse the effect of Abca12 deficiency (Fig. 2C ).
In addition to the LXR-dependent regulatory pathway, murine cells can activate Abca1 expression and cholesterol efflux in response to treatment with cAMP (Haidar et al., 2002; Le Goff et al., 2006) . When RAW 264.7 Abca12 knockdown cells were activated with cAMP, (Fig. 2G ,H). Transfection with Lxrβ cDNA alone had no effect (Fig. 2G ).
These findings confirmed that the effect of Abca12 deficiency on cholesterol efflux and Abca1 abundance is at least partially mediated by Lxrβ. Together these data demonstrate that Abca12 regulates Lxrβ abundance and Abca1 protein levels and functionality via a posttranscriptional mechanism.
Mechanisms of modulation of cholesterol efflux by Abca12
Previous studies have proposed that LXRβ can directly bind to ABCA1 reducing its activity and that LXR agonists interfere with this interaction reversing the inhibitory effect of LXRβ (Hozoji-Inada et al., 2011) . A further post-translational mechanism that regulates ABCA1 activity and abundance is its re-localization: when ABCA1 is displaced from the cell surface it no longer supports cholesterol efflux and is rapidly degraded (Neufeld et al., 2001 ).
We therefore investigated the effects of Abca12 deficiency on Abca1 localization and colocalization of Abca1 and Lxrβ. Abundance of Abca1 in non-activated RAW 264.7 cells was low and there was a degree of co-localization of Abca1 and Lxrβ (co-localization coefficient: 0.56±0.09) (Fig. 3A-C) . In cells activated with LXR agonist the abundance of Abca1 increased considerably, but co-localization of Abca1 and Lxrβ did not change significantly compared to the non-activated cells (co-localization coefficient: 0.51±0.04) (Fig. 3D-F) .
Remarkably Clearly, Abca12 is able to regulate the stability of Abca1. To investigate whether a physical interaction between Abca12, Abca1 and Lxrβ may form the basis for these effects, we employed a proximity ligation assay (PLA) (Baima et al., 2010) . In this assay the number of fluorescent dots in a given cell is proportional to the number of interaction events between a 9 pair of heterotypic proteins. When the Abca12/Abca1 pair was studied, an abundant interaction was found and knockdown of Abca12 significantly reduced this interaction ( We also observed an abundant interaction between Abca12 and Lxrβ, which was reduced when Abca12 was knocked-down ( Fig. 3R ).
We next examined HeLa cells stably transfected with GFP-ABCA1 expressed under the control of a CMV promoter (parental HeLa cells do not express homologous ABCA1) (Mukhamedova et al., 2007) . When HeLa-ABCA1 cells were transfected with tGFP-ABCA12, the abundance of ABCA1 significantly increased (Fig. 4A ). Overexpression of ABCA12 in HeLa cells caused modest elevation of cholesterol efflux, however in HeLa/ABCA1 cells this overexpression did not increase cholesterol efflux in addition to that caused by the presence of heterologous ABCA1 (Fig. 4B ). We then investigated the distribution of ABCA1 and ABCA12 by confocal microscopy. Consistent with previous reports (Mujawar et al., 2006; Mukhamedova et al., 2007) most of the ABCA1 in HeLa/ABCA1 cells localized to the perinuclear area with a smaller proportion localized at the plasma membrane (Fig. 4C ). Transfection with ABCA12 caused re-distribution of ABCA1 to the outer cytoplasm and plasma membrane ( Fig. 4D ), similar to the distribution of ABCA12 (Fig. 4E) ; there was a significant co-localization of ABCA1 and ABCA12 (Fig. 4F ).
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To investigate if overexpression of ABCA12 affected stability of ABCA1 we used biotin labelling of cell surface ABCA1 and found that while the abundance of total ABCA1 was considerably higher in cells transfected with ABCA12 (Fig. 4G , lane 1), levels of ABCA1 at the cell-surface were similar (Fig. 4G , lane 2). This observation explains the lack of effect of ABCA12 on cholesterol efflux in HeLa/ABCA1 cells. The rate of degradation of biotinylated ABCA1 was significantly reduced by ABCA12 (Fig. 4G ,H).
In pulldown experiments, anti-ABCA1 antibody co-precipitated ABCA12 irrespective of whether or not proteins were cross-linked prior to immunoprecipitation (Fig. 4I ). In the reciprocal experiment, when ABCA12 was immunoprecipitated, ABCA1 coimmunoprecipitated with ABCA12 ( Fig. 4J ). When LXRβ was immunoprecipitated from
HeLa/ABCA1 cells transfected with ABCA12, both ABCA1 and ABCA12 coimmunoprecipitated with LXRβ (Fig. 4K) . Experiments with the PLA assay confirmed interaction between ABCA1 and ABCA12 in this model (Fig. 4L ). They also revealed that overexpression of ABCA12 increased interaction of ABCA1 and LXRβ and caused a relocalization of this complex to a region surrounding the nucleus (Fig. 4M) . Note that cells in this experiment were not treated with LXR agonist and that the abundance of ABCA1 was elevated in cells overexpressing ABCA12.
Together these findings indicate that ABCA12 interacts with ABCA1 and that loss of ABCA12 reduces ABCA1 abundance on the cell surface and enhances its degradation.
ABCA12 and ABCA1 are also likely to interact with LXRβ. Table S2 .
Abca12 deficient macrophages accumulate cholesterol
Taken together these findings demonstrate that Abca12 deficiency results in the accumulation of lipids in macrophages.
Loss of Abca12 impairs reverse cholesterol transport and promotes atherosclerosis in vivo
We next assessed the effect of Abca12 deficiency on reverse cholesterol transport (RCT) in vivo. RAW 264.7 macrophages transfected with control or Abca12 siRNA were loaded with cholesterol, labelled and transplanted into the peritoneal cavity of mice. The amount of labelled cholesterol exported from macrophages with Abca12 knockdown to plasma and feces was reduced 2-fold compared with control macrophages (Fig. 6A,C) . The amount of cholesterol in the liver was unaffected (Fig. 6 B Fig. 6D,H ; p<0.002).
The biggest effect was observed in the aortic arch, the area most susceptible to the development of atherosclerosis, (Fig. 6 E,H ). There was a trend toward increased atherosclerosis in the thoracic aorta (Fig. 6 F) while no difference was found in the abdominal aorta (Fig. 6 G) . Analysis of cross-sections of the aortic sinus revealed no difference between the two groups of mice in the abundance of macrophages in the plaque and expression of VCAM-1 on the surface of endothelium (Fig. 6 I,J) . We found no difference in the abundances of collagen (Fig. 6 K) , a marker of protein oxidation, nitrotyrosine (Fig. 6 L) or in the size of the necrotic core (Fig. 6 M) .
Blood cell counts in the two groups of mice after 16 weeks on high-fat diet revealed two statistically Table S3 ), indicating that the enhanced atherosclerosis was not the result of changes in plasma lipid profile.
These results indicate that Abca12 deficiency inhibits RCT in vivo and causes accumulation of cholesterol in macrophages promoting their transformation into foam cells and contributing to the development of atherosclerosis.
Discussion:
ABCA12 is a full-length ubiquitously-expressed ABC transporter. In skin, ABCA12 is responsible for transport of ceramides and its mutation leads to defects in skin barrier function, leading to dehydration (Kelsell et al., 2005) . Recently we (Smyth et al., 2008) and others (Yanagi et al., 2008; Zuo et al., 2008) and exceptional susceptibility to lipid overloading (Smyth et al., 2008) . These findings suggested that the physiological role of ABCA12 may not be limited to skin and may be an element of a novel pathway regulating lipid metabolism in various tissues including macrophages, cells central to the development of atherosclerosis.
The main finding of this study is that ABCA12 is essential for the regulation of cellular deficiency in the development of atherosclerosis. Our findings also suggest that ABCA12 defines a part of a novel pathway involved in regulation of cholesterol homeostasis and a potential contributor to the development of atherosclerosis.
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Experimental Procedures:
Cells
The Abca12 El12 and Abca12 Lx12 mouse strains were described previously (Smyth et al., 2008; Yanagi et al., 2010) . Abca12 El12 mice were backcrossed for 10 generations and the mutation was mapped to a narrow 4.7 Mb interval, only Abca12 gene in this interval was found to be altered. The uterus was removed on embryonic day (E)12.5 of pregnancy and embryos were isolated under aseptic condition. The embryonic liver was dissected; cells suspended and cultured in 6-well tissue culture plate in RPMI-1640 medium containing 10% FBS and 20%
L929-cell conditioned medium as source of colony stimulating factors as described by Feng et al (Feng et al., 2005) . After 24-hour depletion of adherent cells and debris, non-adherent macrophages are removed to fresh Petri dishes and grown to confluence. Embryos were genotyped and cultured macrophages were characterized morphologically as described by Suzuki et al (Suzuki et al., 2000) ; 95% of cells were deemed to be macrophages.
RAW 264.7 cells were maintained as described previously (Mukhamedova et al., 2008) .
HeLa-ABCA1 cells stably expressing GFP-tagged ABCA1 were a kind gift of Dr. A.
Remaley and were described by us previously (Mukhamedova et al., 2007) .
Transfections
RAW 264.7 mouse macrophages were transfected with Abca12-specific siRNA or scrambled siRNA (control) and treated with TO-901317 (4 µM) for 18 hours. Transfection was performed using Lipofectamine RNAi MAX (Invitrogen) following manufacturer's protocol.
Abca12 siRNA and scrambled siRNA were from Santa Cruz Biotechnology.
Lxrβ and murine Abcva12 genes were inserted into pCMV6-AC-GFP plasmid (Origene).
Human ABCA12 plasmid was a kind gift of Prof. D. Kelsell. Transfections with Lxrβ plasmid were performed as described previously (Escher et al., 2005) . Transfection of HeLa cells with ABCA12 plasmid was conducted as described previously (Mukhamedova et al., 2007) .
HDL and apolipoprotein A-I
High density lipoprotein (HDL) (1.083<d<1.21 g/L) was isolated by sequential centrifugation in KBr solutions, delipidated and apoA-I was purified by gel filtration chromatography as previously described (Brace et al., 2010) .
Cholesterol efflux
Cholesterol efflux was measured as described previously (Mukhamedova et al., 2008) .
Briefly, cells were incubated in serum-containing medium supplemented with [ 
Western blot analysis
The antibodies against ABCA1, ABCG1, SR-B1, LXRα, LXRβ, and GAPDH were from in PBS, then chased in RPMI medium supplemented with 1.5 mg/ml L-methionine and 0.5 mg/ml L-cysteine (Sigma Aldrich) for the indicated times. ABCA1 protein was determined by immunoprecipitation with an affinity purified rabbit anti-ABCA1 antibody, separated by SDS-PAGE, transferred to PVDF membrane, and exposed to autoradiography film.
Biotinylation of cell-surface proteins
Cells were washed 3 times with ice-cold PBS and biotinylated with Sulfo-NHS-SS-biotin as described previously (Cui et al., 2012) . After biotinylation, cells were washed twice with 50 mM Tris/150 mM NaCl to quench the reaction and once with PBS. Following incubation in serum-free RPMI medium at 37°C for 0 h, 4 h or 24 h, cells were lysed with RIPA buffer.
Biotinylated proteins were purified using Ultralink Plus immobilized streptavidin gel (Pierce).
Cholesteryl ester biosynthesis
Cells were incubated for 18 h in serum-containing medium in the presence or absence of 50 µg/ml of acetylated LDL. Cholesteryl ester biosynthesis was then assessed by incorporation of [ 14 C] oleic acid into cholesteryl esters over 2 h as described previously (Mujawar et al., 2006) . Staining of cells with Oil Red O was described previously (Smyth et al., 2008) .
Real-time PCR
PCR primers were obtained from Taqman® Gene Expression Assays with follow gene assay
Mm00440169_m1, Mm01282499_m1). Real-time PCR reactions were performed on 7500
Fast System from ABI Applied Biosystems. The relative amount of mRNA was calculated using the comparative C T method. Gene expression was normalised to 18s rRNA.
Lipidomics
RAW264.7 cells were transfected with siRNA Abca12 or siRNA C , activated with 4 µM TO-901317 for 24 hours, and incubated with or without 50 µg/ml acetylated LDL overnight.
Cells were washed with PBS, resuspended into 20mM Tris/500mM NaCl solution containing 20 0.1 mM butylated hydroxytoluene and sonicated. Ten microlitres (20 µg of protein) each of the supernatant were subjected to lipids extraction and analysis using mass spectrometry.
Confocal microscopy
For imaging, RAW 264.7 or Hela-ABCA1 cells were grown in Lab-Tek Chamber Slide system (Nunc). In HeLa-ABCA1 cells ABCA1 was fused with GFP, in RAW 264.7 cells it was stained with monoclonal anti-ABCA1 antibody ( antibody. Co-localization was quantitated using Zeiss LSM image analysis software as described by Zinchuk et al (Zinchuk and Grossenbacher-Zinchuk, 2011; Zinchuk et al., 2007) and expressed as unweighted co-localization coefficient of Lxrβ with Abca1on full images (10 images, 6-8 cells per image, 3 experiments).
In situ proximity ligation assay (Duolink)
The general principle of the Duolink in situ co-immunoprecipitation assay has been described previously (Baima et al., 2010) . Cells were seeded at 1x10 4 cells per well on 8-well Lab-Tek 
In vivo reverse cholesterol transport assay
Cholesterol efflux in vivo was measured using a model described by Rader (Wang et al., 2007) with modifications described previously (Mukhamedova et al., 2008) .
Bone marrow transplantation
After backcrossing 10 generations to C57BL/6, the Abca12 El12 mutation was backcrossed onto a C57BL/6 Apoe-deficient background. C57BL/6 CD45.2 Abca12 -/+ Apoe -/-mice were then intercrossed and E13.5 livers harvested from embryos. Two million fetal liver cells were transplanted into adult C57BL/6 CD45.1 Apoe -/-recipients in whom endogenous hematopoiesis has been ablated by irradiation (11 Gy in 2 equal doses 2-3 hours apart). Eight weeks post-transplantation, donor engraftment was determined by flow cytometric analysis of peripheral blood leukocyte in conjunction with CD45-specific monoclonal antibody. Eight weeks post-reconstitution, bone marrow chimera mice were put on a high fat diet (21% fat, 0.15% cholesterol) for 16 weeks. Lipid accumulation and distribution and size (area) of atherosclerotic lesions in aorta were quantitatively assessed using en face analysis after staining with Sudan IV.
Heart tissue containing the aortic sinus was embedded in OCT compound (Tissue-Tek) and frozen for assessment of plaques within the aortic sinus region. Consecutive 10μm sections spanning 240μm of the aortic sinus were cut and collected. Sections were stained with
Masson's trichrome stain to detect collagen. Sections were also examined for macrophage content, as well as inflammatory and oxidation markers by immunohistochemistry using the 22 following primary antibodies: anti-CD68 (AbD serotec), anti-VCAM-1 (BD Pharmingen),
anti-Nitrotyrosine (Millipore). Images were quantified using ImagePro plus 6.0 software.
All animal experiments complied with the regulatory standards of, and were approved by, the Walter and Eliza Hall Institute Animal Ethics Committee and/or the AMREP Animal Ethics
Committee.
Statistics
All in vitro experiments were performed in quadruplicates and repeated 2-3 times. Statistical analysis was made using Student's t-test and one-way ANOVA modified by the step down Bonferroni procedure; both tests produced identical results. Means ± SEM are shown. "Inactive" ABCA1 exists as a complex with ABCA12 and LXRβ. Addition of an LXR agonist leads to dissociation of LXR from ABCA1-ABCA12 and activation of ABCA1, enabling it to hydrolyse ATP, bind apoA-I and remain on the cell surface where it is stable. In the absence of ABCA12, LXRβ binds more firmly to ABCA1 and this association is not broken by LXR agonist; consequently ABCA1 remains inactive and unstable.
Overexpression of LXRβ leads to the excess of LXRβ and formation of LXRβ dimers in the presence of an agonist; these dimers dissociate from ABCA1.
